GILD
Gilead Sciences Inc
Price:  
72.31 
USD
Volume:  
5,317,576.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead WACC - Weighted Average Cost of Capital

The WACC of Gilead Sciences Inc (GILD) is 8.2%.

The Cost of Equity of Gilead Sciences Inc (GILD) is 9.35%.
The Cost of Debt of Gilead Sciences Inc (GILD) is 5.00%.

Range Selected
Cost of equity 8.10% - 10.60% 9.35%
Tax rate 20.20% - 22.90% 21.55%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 9.1% 8.2%
WACC

Gilead WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.92 1.02
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 10.60%
Tax rate 20.20% 22.90%
Debt/Equity ratio 0.28 0.28
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 9.1%
Selected WACC 8.2%